| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |